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HS (heparan sulfate) has been shown to be an important mediator
of Plasmodium sporozoite homing and invasion of the liver, but
the role of this glycosaminoglycan in mosquito vector host–
sporozoite interactions is unknown. We have biochemically
characterized the function of AgOXT1 (Anopheles gambiae
peptide-O-xylosyltransferase 1) and conﬁrmed that AgOXT1
can modify peptides representing model HS and chondroitin
sulfate proteoglycans in vitro. Moreover, we also demonstrated
that the mosquito salivary gland basal lamina proteoglycans are
modiﬁedbyHS.WeusedRNAinterference-mediatedknockdown
of HS biosynthesis in A. gambiae salivary glands to determine
whether Plasmodium falciparum sporozoites that are released
frommosquitomidgutoocystsusesalivaryglandHSasareceptor
for tissue invasion. Our results suggest that salivary gland basal
lamina HS glycosaminoglycans only partially mediate midgut
sporozoite invasion of this tissue, and that in the absence of HS,
the presence of other surface co-receptors is sufﬁcient to facilitate
parasite entry.
Key words: Anopheles, cell invasion, glycobiology, glycos-
aminoglycan (GAG), heparan sulfate (HS), malaria.
INTRODUCTION
Malaria transmission entails development of the Plasmodium
parasite in the mosquito. There are two major tissues that
the parasite must traverse during its development in the mos-
quito. The ﬁrst obligatory step requires recognition and
attachment of the Plasmodium ookinete stage to lumenal
membraneligandsofthemosquitomidgutepitheliumfollowedby
active cell invasion [1]. We have previously identiﬁed the critical
interaction between the ookinete and CS (chondroitin sulfate)
GAGs (glycosaminoglycans) on the mosquito midgut lumenal
proteoglycans. Disruption of AgOXT1 (Anopheles gambiae
peptide-O-xylosyltransferase 1) activity in the midgut, which
blocks GAG biosynthesis, resulted in 95% inhibition of ookinete
invasion of the midgut. These data conﬁrmed the hypothesized
role of these anionic polysaccharides in the initial adhesion of
the ookinete, directly preceding invasion and establishment
of oocysts on the midgut basal wall [2].
The second fundamental step in the sporogonic cycle is the
transmission of sporozoites that have developed in the oocyst
beneath the midgut basal lamina into a new vertebrate host. To
achieve this, sporozoites must ﬁrst reach, recognize and attach
to the salivary glands of the mosquito [3]. Once in the salivary
glands, the sporozoites can now be delivered to a new vertebrate
host when the mosquito takes another bloodmeal.
There are two major surface molecules that are conserved
on both midgut (oocyst-derived) sporozoites and salivary
gland sporozoites: CSP (circumsporozoite protein) and TRAP
(thrombospondin-related adhesion protein). It has been shown in
the vertebrate system that CSP [4] and TRAP are involved in
hepatocyte homing and attachment in the vertebrate host [5]. CSP
recognizes HSPGs [HS (heparan sulfate) proteoglycans], which
extend out through the endothelium from the basolateral surfaces
of hepatocytes [6–9]. TRAP also exhibits binding afﬁnity for
heparin, HS, dextran and fucoidin, but not for bovine cartilage-
derived CS [10–12]. More importantly, both CSP and TRAP have
been implicated in salivary gland invasion by midgut sporozoites
[13,14]. However, to date, it has not been shown that GAGs are
involvedinmidgutsporozoiteinteractionwiththesalivaryglands.
It has been hypothesized that although the protein backbone of
HSPGs may differ between the basal membrane of hepatocytes
andmosquitosalivaryglands,theGAGchainsmaybestructurally
conserved, thus conferring sporozoite tropism for both tissues in
two evolutionarily divergent hosts. Previously, it was shown that
enzymatic treatment of Anopheles stephensi mosquito salivary
glands to release GAG disaccharides identiﬁed a HS moiety
that is structurally similar to those found on liver HSPGs [15].
Bolstered by this ﬁnding, we subsequently hypothesize that the
parasite switches ‘preference’ from CSPGs (CS proteoglycans)
[2] to HSPGs as binding ligands, probably as a function of the
availability of these molecules along the appropriate ‘face’ of
polarizedepithelia[16]asisfoundinboththemidgutandsalivary
gland tissues. Ookinetes invade through the apical domain of
the midgut, where CSPGs predominate [2], whereas sporozoites
can only interact with the basal face of the salivary gland
HSPGs (since sporozoites invade from the haemocoel of the
mosquito). To test this, we ﬁrst had to demonstrate that (i) a
salivaryglandpolypeptide-OXTfromthemalariavectormosquito
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Anopheles gambiae can initiate both heparan and chondroitin
GAG biosynthesis, and (ii) that HSPGs are localized to the basal
lamina of mosquito salivary glands. We report the veriﬁcation of
the enzymatic function of AgOXT1, the successful knockdown
of HS biosynthesis in A. gambiae salivary glands by RNAi (RNA
interference), which in turn permitted the analysis of the role of
HSGAGs (HS glycosaminoglycans) in Plasmodium falciparum
sporozoite invasion of the salivary gland.
EXPERIMENTAL
Biological materials
Anophelesgambiae(strain Keele) wererearedfollowing standard
protocols as described elsewhere [2], with the following
modiﬁcations. Larvae were raised at a lower density (100–
150/pan) to allow for the generation of larger female mosquitoes
(with estimated wing length measurements >3 mm and relatively
larger body mass). To ensure mosquito survival success for the
salivaryglandinvasioninhibitionassay(describedbelow),female
mosquitoesofsimilarmetabolicandphysiologicalagewereused.
Only 5–6-day-old females that met the above size requirements
were used for these experiments.
Cloning of xylosyltransferase cDNA fragment and expression
in yeast
A cDNA fragment encoding the predicted catalytic domain of
AgOXT1(VectorBaseaccessioncodeAGAP005811;http://www.
vectorbase.org) was isolated by RT (reverse transcription)–
PCR using the primers AgOXT1/1/EcoRI (5
 -CGGAATTCGAC-
TTTGTGCCGCCGTG-3
 ) and AgOXT1/2/XbaI (5
 -GCTCT-
AGAACTAGTTCGACGTTACCGATTC-3
 ) from midgut cDNA
and Expand polymerase mix (Roche) in the presence of
a ‘GC-rich’ polymerase buffer additive. The ∼2.5 kb band
was excised from an agarose gel, extracted and ligated into
the pGEM-T vector (Promega). The plasmid DNA from one
clone was digested with EcoRI and XbaI, and the ∼2.5 kb band
was excised and extracted prior to ligation into the pPICZαC
vector cut with the same enzymes. Plasmid DNA from a
selected positive Escherichia coli clone was subjected to DNA
sequencing and used to transform Pichia pastoris GS115 cells
usingZeocin
TM (phleomycin)selection.Forselectedyeastclones,
expression was induced using methanol as described previously
[17] and xylosyltransferase assays were performed using the
crude supernatant. One clone was used for a larger-scale culture
and the PMSF-treated culture supernatant was subjected to
ammonium sulfate precipitation. The 40% pellet was dissolved
in a 10 mM Hepes, pH 8, buffer (containing 1 mM PMSF as a
protease inhibitor and 0.01% sodium azide) and was found to
contain the maximal activity; this preparation was desalted using
an Ultrafree® centrifugal ﬁltration device and was the source
of enzyme for the subsequent enzymatic characterization. The
enzyme could be stored at 4◦C for several weeks, retaining at
least 50% of its activity after 3 months.
Enzymatic characterization
Xylosyltransferase assays were performed basically as described
previously [17–19], routinely using a ﬁnal concentration of
1 mM syndecan peptide (Syn; DDDSIEGSGGR), 2 mM UDP-
Xyl (xylose), 80 mM Hepes, pH 8, and 10 mM MnCl2; one-third
of the volume was accounted for by the enzyme preparation.
The incubations were normally performed at 30◦Cf o r2 hi n
PCR tubes (either 2.5 μlo r1 0 μl total volume) prior to heat
inactivation at 95◦C for 10 min; overnight incubations with
three other peptides [Bik (bikunin), Syn2 and Perl (perlecan)]
were also performed. For determination of the pH optimum,
AMPD (2-amino-2-methyl-1,3-propanediol) buffers were used;
for examination of the cation dependency, MnCl2 was replaced
with other metal chlorides or by EDTA. The conversion into
product was examined by RP-HPLC (reverse-phase HPLC) or by
MALDI–TOF-MS (matrix-assisted laser-desorption ionization–
time-of-ﬂight MS). For RP-HPLC, a Nucleosil C18 column
was used with a gradient of acetonitrile (9–12% acetonitrile
from 5–15 min); peptides were detected by measuring A214 and
product/substrate ratios were calculated based on integrated
peak areas. MALDI–TOF-MS and MS/MS (tandem MS) were
performed with a Bruker Ultraﬂex TOF/TOF instrument with α-
cyanohydroxycinnaminic acid as matrix.
Semi-quantitative RT–PCR
The AgOXT1 primers 1557F (5
 -CAGCACAAGAAGCTGTT-
CTTTGGC-3
 ) and 2337R (5
 -AGCTTCCGTGACGAGAAA-
TCGTGT-3
 ) were used to amplify a 780 bp product
correspondingtotheC-terminusofAgOXT1fromourA.gambiae
midgut cDNA library. The PCR product was cloned into the
pJET1.2/blunt vector (Fermentas). Cloned PCR products were
conﬁrmed by DNA sequencing. For RT–PCR, 50 ng of total
salivary gland RNA (n=8–12 female salivary gland pairs)
collected from each time point after injection was reverse-
transcribed using RevertAid
TM M-MuLV Reverse Transcriptase
(Fermentas) following standard protocols. AgOXT1 transcript
abundance was determined by using the primers described
above. The ampliﬁed A. gambiae ribosomal protein gene (AgS7)
product was used as a loading control (AgS7F, 5
 -GGCGATCA-
TCATCTACTTGC-3
 ;a n dA g S 7 R ,5
 -GTAGCTGCTGCAAA-
CTTCGC-3
 ).AmpliﬁcationusingKlenTaqLADNApolymerase
(Sigma)was performedasfollows: 95◦Cfor1min,94◦Cfor30 s
and 68◦C for 3 min, with a ﬁnal extension at 68◦Cf o r3m i n( 3 0
cycles).
RNAi
AgOXT1 dsRNA (double-stranded RNA) was produced by using
the primers described above with the T7 polymerase promoter
sequence, 5
 -TAATACGACTCACTATAGGG-3
 , appended to
the 5
  termini of each primer and transcribed in vitro using the
MEGAscript® RNAi kit (Ambion) as per the manufacturer’s
protocols. The dsRNA solution was diluted to 6 μg/μli n
sterile injection buffer (10 mM Tris/HCl, pH 7.4). A. gambiae
females were anaesthetized by cold treatment and inoculated
intrathoracically using a mineral oil back-ﬁlled borosilicate
capillary needle and a Nanoject II instrument (Drummond
Scientiﬁc) with 400 ng of dsRNA or control dsGFP [GFP (green
ﬂuorescent protein) dsRNA]; the injection of dsGFP has been
consistently shown to be the best control for injury imparted by
dsRNAinjectionintothemosquitohaemocoelviaaneedle[2,20].
Initially, uninfected mosquitoes were kept for 2–5 days to collect
RNA and protein from salivary glands at the prescribed time
points. Replicate reproducible knockdown of transcript would
provide conﬁdence that during the course of the salivary gland
invasion inhibition assay (see below), AgOXT1 message would
be likewise repressed. Note that there is no evidence which
demonstrates that infection of the mosquito with Plasmodium
oocystsresultsinthelossofefﬁcacyofRNAi-mediatedsilencing.
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SDS/PAGE and semi-quantitative Western blot analysis
Mosquito salivary gland lysates (n=20 female salivary gland
pairs) were fractionated on a 10% Tris/glycine gel and
transferred to nitrocellulose membranes. Transblots were probed
with RB4Ea12 anti-HS scFv (single-chain variable fragment)
antibodies (1:25) overnight at 4◦C [21]. For RB4Ea12 detection,
amouseanti-VSV(vesicularstomatitisvirus)secondaryantibody
(1:100; Sigma) was used followed by either Alexa Fluor®
488 (Invitrogen)-conjugated anti-mouse (1: 1000) or an IRDye
800CW (LI-COR) anti-mouse tertiary antibody (1:40000)
staining.
We also cloned a 456 bp fragment of the gene encoding
AgLDH (A. gambiae L-lactate dehydrogenase; VectorBase
accession code AGAP004880) from midgut cDNA using
the following primers (AgLDH forward, 5
 -CACCATGT-
CTGAAGTGAAAGCTAAGCTG-3
 ;a n dA g L D Hr e v e r s e ,5
 -
GACGACCAACAGAATGCAGTCCGGGCT-3
 ) and expressed
the protein using the vector pBAD202 (Invitrogen) in E. coli.
RecombinantsolubleproteinwaspuriﬁedusingNi–agarosebeads
(Qiagen). Rabbit polyclonal antiserum was generated against
the puriﬁed recombinant protein (Washington Biotechnology).
AgLDH (VectorBase accession code AGAP004880) is expressed
in sugar-fed midguts and is predicted to give rise to three splice
variants(VectorBaseaccessioncodesAGAP004880-RA,-RBand
-RC)ofapproximately1452 bp.Weonlyclonedandexpressedthe
protein product of AGAP004880-RA. Anti-AgLDH antibodies
(1:200) as loading control probes were used to stain the blot
overnight at 4 ◦C and then detected by IRDye 680 goat anti-rabbit
antibody (1:40000). Anti-AgLDH antibodies detected a single
protein band with the predicted molecular mass of ∼35 kDa
for all three gene products (results not shown). Transblots
were imaged using an Odyssey® Infrared Imaging System
(LI-COR).
Immunoﬂuorescence analysis
WholesalivaryglandpairsfromfemaleA.gambiaeweredissected
in PBS with protease inhibitor cocktail (Sigma) before being
ﬁxed with 4% paraformaldehyde for 30 min on ice. Fixed
glands were blocked with 3% BSA/PBS overnight at 4◦C. As
was performed for the Western blots, RB4Ea12 scFv antibodies
(1:25) were incubated with tissues at 4◦C overnight. After
extensive washing, scFv staining was detected by successive
incubations with mouse anti-VSV antibody (1:100; Sigma), a
second wash step and then the addition of goat anti-mouse Alexa
Fluor® 488- or Alexa Fluor® 594-conjugated tertiary antibodies.
The slides were mounted with SlowFade® reagent containing
DAPI(4
 ,6-diamidino-2-phenylindole)(Invitrogen),visualizedby
microscopy (×400) and image-captured by SPOT RT software
(v. 3.2).
Salivary gland invasion inhibition assay
P. falciparum gametocyte cultures from isolate NF54 (Sanaria)
were maintained at the Johns Hopkins Malaria Research Institute
Parasite Core Facility. Cultures were harvested 15–17 days after
initiation. The culture was washed and raised in normal human
serum (Interstate Blood Bank) plus human red blood cells at
0.3% gametocytaemia in a 45% haematocrit. Infective blood
wasdelivereddirectlyintoglasswater-jacketedmembranefeeders
warmed to 38 ◦C. Robust female mosquitoes (5–6 daysold) were
allowed to blood feed for 20 min. Unfed mosquitoes
were removed from the cups. At 9 days after being fed a blood
meal containing P. falciparum gametocytes, infected A. gambiae
females that exhibited egg development, as a proxy measure
for feeding to repletion, were anaesthetized by cold treatment
and inoculated intrathoracically with 400 ng of dsAgOXT1
(AgOXT1 dsRNA) or control dsGFP (see above). Mosquitoes
were maintained for an additional 3 days, at which point (day
12 post-infection) surviving mosquitoes were knocked down by
cold treatment to collect infected salivary glands. Salivary gland
invasionbyP.falciparumsporozoitesbeginsatapproximately10–
14 days post-midgut infection. Salivary glands were harvested at
day 12 post-infection, which essentially captures all sporozoite
invasion events that had occurred during a 48 h time period.
A minimum of 19–20 salivary gland pairs were dissected
for control (dsGFP) and treatment (dsAgOXT1) groups and
placed into tubes containing PBS. Each salivary gland pair was
crushed with a pestle in a microcentrifuge tube to release the
sporozoites. Tissue material was pelleted at 6000 g for 2 min,
the supernatant (20 μl) was collected and the sporozoites were
counted using a haemocytometer. The isolation was repeated and
the supernatants pooled. Two independent experiments (19–24
salivary gland pairs/assay) were performed. The raw data for
infection intensity and prevalence in controls were analysed
for equality of variance (P= 0.3049), demonstrating that these
two biological replicates were comparable. The D’Agostino–
Pearson omnibus normality test was also performed to
determine the most appropriate statistical analysis. Non-
parametric statistical analysis was used to evaluate the difference
in median sporozoite infection between experimental and control
groups (Mann–Whitney U test, one-tailed, α =0.05) using
StatView 5.0 software (SAS Institute).
RESULTS
Enzymatic properties of AgOXT1
We have conﬁrmed previously that there is only a single AgOXT1
gene that is transcribed in the A. gambiae genome [2] and, as
such, the underlying assumption is that this single peptide OXT is
involved in both CS and HS biosynthesis. This would imply that
AgOXT1 can modify serine residues within predictable sequons
on CSPGs and HSPGs. It was imperative that we conﬁrmed the
function of AgOXT1 before pursuing knockdown approaches. If
thisgenedidnotmodifyserineresiduesonknownHSPGacceptor
peptides, then it would clearly be an invalid target gene to knock
down for our subsequent experiments.
We veriﬁed the biochemical function of AgOXT1 in vitro
using a truncated form of the enzyme lacking the cytosolic,
transmembrane and putative stem regions, but retaining the
conserved P-X-C-D/E motif in a Pichia secreted expression
system; Pichia cultures have been shown previously to secrete
no background xylosyltransferase activity [17,19], which also
reﬂectstherestrictionofOXT genestometazoans.Variouspeptide
acceptorsubstrateswereusedinthepresentstudy:apeptidebased
on a part of the sequence of bikunin (Bik, QEEEGSGGGGQR),
two variants of a sequence based on amino acids 55–65 from
Drosophila syndecan (Syn, DDDSIEGSGGR, and the artiﬁcial
variant Syn2, DDDSIEGSGSGGR, which has two Ser-Gly
motifs) and a sequence based on part of human perlecan (Perl,
DSISGDDLGSGDLGSGDFQR).BikuninisaKunitz-typeserine
protease inhibitor in vertebrate serum and urine modiﬁed by a
singleCSchain[22],whereassyndecansaremodiﬁedbyHS[23];
perlecanscarrybothCSandHSchains[24].Allsubstratesharbour
an acidic region as well as a Ser-Gly sequence, which have been
describedpreviouslyforCSandHSmodiﬁcationsites[25,26].We
observedthattherAgOXT1(recombinantAgOXT1)transferreda
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Figure 1 MALDI–TOF-MS and HPLC-based assays for xylosyltransferase activity
(A–H) Incubation of selected peptides with the recombinant enzyme preparation was performed overnight in the presence (A,C,E,G) or absence (B,D,F,H) of UDP-Xyl as enzyme donor. In all
cases, the xylosyltransferase transferred Xyl (indicated by  m/z =132; one in the case of the Bik, Syn and Syn2 peptides, and two in the case of the Perl peptide); asterisks in (G and H) indicate
contaminating peptides originating from the culture medium. (I) A typical RP-HPLC assay is depicted showing the UDP-Xyl-dependent formation over 2 h by AgOXT1 of a product with a slightly
earlier elution time; product (Xyl-Syn) and substrate (Syn) peaks were collected and subject to MALDI–TOF-MS (J, K) to show the respective presence of species of m/z 1239 and 1107. The
comparative MALDI–TOF-MS/MS data for the two peaks (L, M) verify the transfer of Xyl to the second serine residue of the DDDSIEGSGGR sequence of the Syn peptide (fragments of m/z 564 in D
and 432 in both D and E); loss of Xyl directly from the parent ion in D is also apparent. The  m/z values between peaks correspond to either single amino acids (D, E, G, R), dipeptides (G+G, I+S,
S+G) or xylosylserine (S+Xyl).
singleXylresidue(indicatedbya m/zof132)totheBik,Synand
Syn2 peptides (Figures 1A–1F); the RP-HPLC-based assay
and analysis of the relevant collected fractions veriﬁes that Syn
accepts one Xyl residue (Figures 1I–1K). The observation that
Syn2 is only singly xylosylated is in line with previous assays
examining transferase activity of recombinant Caenorhabditis
SQV-6, Drosophila OXT and human XT-I (xylosyltransferase I)
with Syn2 as an acceptor peptide [19]. Furthermore, in the case
of the Perl peptide, rAgOXT1 was observed to transfer two Xyl
residuestotheacceptorpeptidebackbone(Figure1G).Moreover,
wewereabletoconﬁrmthatrAgOXT1modiﬁedthesecondserine
residue in the DDDSIEGSGGR peptide only (Figure 1L). These
results indicate that AgOXT1 can indeed modify both CS and HS
proteoglycan core proteins in the mosquito.
We also determined the activity of rAgOXT1 by RP-HPLC-
based assays (Figure 2) and observed a pH optimum of 8, a
temperature optimum of 37◦C and a cation dependence of the en-
zyme that is similar to that for recombinant forms of human XT-I
and Drosophila OXT. Using the temperature-dependence data, an
Arrhenius plot suggested an activation energy, Ea,o f∼39 kJ/mol
(∼9 kcal/mol). The enzyme is still active in the absence of added
cation or in the presence of EDTA, but is signiﬁcantly activated
by Ca(II), Mg(II) and Mn(II) ions, and inhibited by Cu(II) and
Zn(II). The Km value for the UDP-Xyl donor is estimated to
be 120 μM and is also consistent with values of 100–250 μM
for the human and Drosophila homologues [18,19]. We know
that mammalian OXT is an intracellular Golgi enzyme [27] and
this is likely to be a conserved localization for mosquito OXTs.
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Figure 2 Enzymatic characterization of AgOXT1
RP-HPLC-basedassayswereusedtodeterminethepercentageconversionover2 hintoproduct
under various conditions to assess (A) optimum pH, (B) cation dependence, (C) optimum
temperatureand (D) Km valuefor thedonorsubstrateUDP-Xyl (Hanes–Woolfplot);the inset in
(D) shows the kinetic curve plotting UDP-Xyl concentration against percentage conversion.
Although the pH optimum that we observed is more in the range
described for the resting state pH for the mosquito midgut [28]
and salivary glands of other haematophagic insects [29], the
optimumpHdescribedforourinvitrostudiesmaynotnecessarily
be relevant in the in vivo context. Similarly, we observed that
rAgOXT1 had greater activity at higher temperatures beyond the
recorded ambient temperatures in malaria-endemic regions (28–
32◦C). However, the conversion rate data points for temperatures
>30◦C overlap, suggesting that this difference is not statistically
signiﬁcant. We speculate that at 30–32◦C AgOXT1 has sufﬁcient
glycosylation activity in the salivary glands.
RNAi-mediated repression of HS biosynthesis
An experimental timeline for RNAi-mediated repression of HS
biosynthesis in A. gambiae salivary glands and its effects on P.
falciparum sporozoite invasion is outlined in Figure 3(A). The
RB4Ea12scFvantibodystainsnon-permeabilizedsalivaryglands
along the basal surface of the tissue with a more prominent
recognition of the distal lateral lobes (Figure 3B, a and b).
Note that mouse anti-VSV antibody and goat anti-mouse Alexa
Fluor®-labelled antibody did not stain the salivary glands (results
not shown). The injection of 400 ng of dsAgOXT1 into adult A.
gambiae signiﬁcantly decreased transcript levels at 72 h, with a
strong rebound in transcript abundance at 96 h (Figure 3C, upper
panel). RNAi-mediated interference is generally regarded as a
leaky method, in that individual mosquitoes that are injected with
dsRNA will have varying levels of knockdown, and is known
to be particularly challenging when targeting mosquito salivary
glands [30]. However, in these small pools of salivary gland pairs
from 8–12 mosquitoes, we observed a pronounced reduction in
AgOXT1messageat72 h.WealsoobservedthereductioninHSPG
staining in representative experiments using Western blotting
(Figure 3C, lower panel) at 72 h post-injection with dsAgOXT1,
demonstrating that AgOXT1 activity is repressed, resulting in
the loss of GAG modiﬁcation of proteoglycans that are present
on the basal lamina of salivary glands. The loading control anti-
AgLDH antibodies recognized a single band of ∼35 kDa and of
equal intensity across both samples. These results highlight the
speciﬁcity of the scFv antibody used in the present study, given
that in the absence of HS, RB4Ea12 scFv does not bind and
cannot be detected by the labelled secondary antibody. Noting the
rebound in transcript at 96 h, we further investigated whether
repression of HS biosynthesis along the basal lamina of the
salivary gland distal lateral lobes was lost at 96 h post-dsRNA
delivery (Figure 3D). We observed that the rebound in mRNA ob-
served by semi-quantitative RT–PCR correlates with recovery
of HS biosynthesis, as detected by RB4Ea12 scFv staining of
the lateral lobes of the salivary glands. Moreover, the success
of RNAi-mediated interference for molecules that are already
present on the tissue of interest is contingent on the turnover
rate of the targeted protein and the physiological state of the
mosquito itself. We suspect that the scFv staining observed for
the distal lobes of the salivary glands from dsAgOXT1-treated
mosquitoes (Figure 3D, a–c) represent basal lamina HSPGs with
a lower rate of turnover. This probably corresponds to the barely
visible protein bands of ∼70 kDa that were observed by Western
blotting (Figure 3C, lower panel, arrowheads) and detected using
a highly sensitive near-infrared imaging system. Taken together,
the results suggest that repression of AgOXT1 activity is lost at
96 h. Therefore, to determine the role of HS on salivary gland
invasion by midgut sporozoites, we had to ensure that salivary
glands were harvested no later than 72 h post-dsRNA inoculation
(as depicted in Figure 3A).
Salivary gland sporozoite infection intensity is partly reduced by
RNAi-mediated silencing of HS biosynthesis
Since we observed that the raw data are skewed (positive kurtosis
and non-Gaussian distribution as determined by a normality
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Figure 3 RNAi-mediated knockdown of HS biosynthesis in salivary glands affects P. falciparum sporozoite invasion
(A) Experimental time line for RNAi experiments shown in Figure 3(C)–3(D) and the salivary gland invasion inhibition assay in Table 1. Each time point represents steps in the experimental process
and indicates the age of the mosquito at the time of manipulation, the point of delivery of the P. falciparum infected bloodmeal, and the point of salivary gland harvest, which is 4 days post-dsRNA
injection(day12post-infectiousbloodfeeding).Thegoldarrowhighlightstheoocystdevelopmentperiodonthemosquitomidgut.Theredarrowhighlightstheperiodwhensporozoitesareescaping
the ruptured oocyst and begin invasion of the salivary glands. Note that some oocysts will rupture earlier given the asynchronous nature of oocyst development in the mosquito. The green arrow
highlightsthe72hwindowwhereinAgOXT1mRNAandHSbiosynthesisisknockeddown(kd).(B)Immunoﬂuorescencestainingofthebasallaminaofaﬁxednon-permeabilizedA.gambiae salivary
gland. DAPI staining identiﬁes nuclei in the tissue and appears blue (panel a). The arrow highlights the surface staining of the medial (ML) and distal lateral (DL) lobes of salivary glands using the
RB4Ea12scFvantibody,whichrecognizes6-O-sulfatedGlcNS/NAc-containingdisaccharides,asdetectedbymouseanti-VSVsecondaryantibodyandgoat-antimouseAlexaFluor® 594-conjugated
tertiary antibody and appears red (panel b). Close-up images using ×400 magniﬁcation. (C) RNAi-mediated knockdown of AgOXT1 transcript in salivary glands measured by semi-quantitative
RT–PCR (upper panel) as well as a representative Western blot using RB4Ea12 scFv antibody of HSPGs that remain present on Anopheles gambiae salivary glands at 72h post-dsRNA delivery.
The wild-type salivary gland HS banding proﬁle is represented by the dsGFP control group. Following dsAgOXT1 injection, the HS staining is reduced (lower panel). Antibodies against AgLDH
(molecular mass ∼35kDa) were used as a protein loading control. Images were acquired using the Odyssey® near-infrared system. Arrowheads indicate two faint bands that are barely detectable
in salivary glands from dsAgOXT1-treated mosquitoes (molecular mass ∼70kDa). (D) Bright-ﬁeld images and immunoﬂuorescence staining of salivary glands, conﬁrming that repression of HS
biosynthesis is lost at 96h, which correlated with the mRNA rebound observed at 96h post-dsAgOXT1 inoculation (panels a–c) as compared with dsGFP controls (panels d–f). RB4Ea12 scFv was
detected by Alexa Fluor® 488-conjugated secondary antibody, and appears green. The images for bright-ﬁeld and ﬂuorescence were acquired at ×200 and ×400 magniﬁcation respectively, and are
representativeimagesofsalivaryglandmatchedpairsformosquitoesfromtwobiologicalcohorts.Imageacquisitionandanalysiswasperformedusingexactlythesameparametersfortreatmentand
control glands. DAPI staining identiﬁes nuclei in the tissue and appears blue. It is clear from the results that the window of opportunity to assess the role of HS in sporozoite invasion of the salivary
glands is within the ﬁrst 72h following dsRNA delivery (indicated as a green asterisk on the timeline shown in (A). Salivary gland harvest at this time point should capture only the ﬁrst 2–3days of
sporozoite tissue invasion events.
test), we used the Mann–Whitney U test to compare the median
numberofsporozoitesthatinvadedthesalivaryglandintreatment
groups compared with control groups for the two biological
cohorts (α =0.05). As mentioned previously, sporozoites begin
to invade the salivary glands at ∼10 days post-infectious blood
feeding. Salivary glands were harvested at day 12 post-infection,
which captures all sporozoite invasion events that had occurred
during a 48 h time period, within the 72 h window for conﬁrmed
suppression of AgOXT1 mRNA. The observed trend was towards
areduction(59–79%)inthetotalsporozoiteinfectionintensityin
dsAgOXT1-treatedmosquitoesforthetwoindependentbiological
experiments (Table 1). Of the two biological cohorts, only the
second experiment exhibited a statistically signiﬁcant and patent
reduction in sporozoite infection intensity among dsAgOXT1-
injected mosquitoes. However, taken together, both experimental
replicates do suggest a trend towards a reduction in sporozoite
number in the absence of HS biosynthesis during the ﬁrst 72 h
following dsRNA delivery. Moreover, the reduction in infection
prevalence between control salivary gland pairs (68–75%)a n d
treatment (50–65%) was also marginal, indicating that although
the overall number of sporozoites that invaded the salivary
glands was inhibited, a subset of sporozoites was nonetheless
successful in invading the tissue. A reasonable expectation is that
ifHSGAGsplayamajorroleinsporozoiteinvasion,thennotonly
infection intensity but also infection prevalence in dsAgOXT1-
treated mosquitoes should be signiﬁcantly lower. These results
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Table 1 RNAi-mediated silencing of AgOXT1 activity resulted in a partial reduction in salivary gland sporozoite infection intensity
The number of sporozoites was determined for each salivary gland pair per mosquito from each treatment and control group from two biological experiments. Independent cohorts of A. gambiae
mosquitoes were infected with P. falciparum (NF54) and then inoculated with dsGFP or dsAgOXT1 at day 9 and harvested at day 12 (corresponding to the 72 h time point following dsRNA delivery
and the absence of HS biosynthesis; see the time line in Figure 3A and the Western blot in Figure 3C, lower panel). The raw data for the dsGFP control cohorts were analysed for equality of variance
(F test, P = 0.3049) to demonstrate that these two biological cohorts had similar parasite infection levels in terms of midgut oocysts at day 8 and salivary gland sporozoites at day 12. Statistical
signiﬁcance was determined by Mann–Whitney U test analysis of median sporozoite numbers for control and treatment groups (α =0.05).
Group n Median number of sporozoites per salivary gland pair (range) Inhibition (%) Prevalence of infection P value
Experiment 1 dsGFP 20 92000 (0–600000) – 75% –
dsAgOXT1 20 38000 (0–250000) 59 65% 0.172
Experiment 2 dsGFP 19 83421 (0–210000) – 68% –
dsAgOXT1 24 17917 (0–90000) 79 50% 0.016
suggestthatHSislikelytobeonlyoneofseveralmacromolecules
that contribute to or mediate sporozoite interaction with the basal
lamina of mosquito salivary glands, but its absence alone is not
sufﬁcient to block parasite invasion.
DISCUSSION
Both Plasmodium CSP and TRAP contain an adhesive TSR
(thrombospondin type 1 repeat domain), which is commonly
found in extracellular proteins that are involved in immunity,
cell adhesion and neuronal development [12,31]. A 20-residue
motif called region II of the CSP TSR has been implicated as the
probableligandintheadhesionofsporozoitestoliverHSPGs[32–
34].AsimilarfunctionhasbeenpostulatedfortheTSRdomainof
TRAP[35,36].However,TRAPcontainsasecondadhesivemotif,
the so-called A domain, a member of the vWFA (von Willebrand
factor type A) protein family, which is necessary for sporozoite
gliding motility, target host cell attachment and invasion [36].
Binding studies with the recombinant A domain and TSR
molecules of TRAP [10,12] suggested that both domains interact
with GAGs on tissue surface proteoglycans, most probably via
clusters of basic and hydrophobic residues.
Following this line of evidence, midgut sporozoites, which
express both CSP and TRAP, have been hypothesized to bind
to anionic polysaccharide ligands present along the basal lamina
of salivary glands [15]. Previously, it was shown biochemically
that A. stephensi salivary gland HS chains actually contained the
criticaltrisulfateddisaccharidesequenceGlcNS6S(N-sulfatedN-
acetylglucosamine)-IdoA2S (L-iduronic acid 2-O-sulfate), which
is also found in human liver HS [15]. This trisulfated HS
disaccharide is the liver receptor for apolipoprotein E and is
also hypothesized to be the binding ligand of CSP found on the
surface of the Plasmodium sporozoite [14,15]. Our present study
further conﬁrms the presence of HSGAGs on the basal lamina of
the medial and lateral lobes of A. gambiae salivary glands. The
RB4Ea12 scFv epitope was originally described as GlcNS6S-
GlcUA-GlcNS3S6S-IdoUA-GlcNS[+/−3S]6S (where GlcUA
is glucuronic acid) with an absolute minimal requirement for
6-O sulfation, which would suggest that the protein bands
that were observed by immunoblotting probably represent only
a subset of salivary gland HSPGs [21,37–39]. Moreover, in
these initial studies the presence of IdoA2S can partly inhibit
binding of RB4Ea12 to HS [21,37–39]. However, recent data
conﬂict with this initial assessment since it appears that a
certain degree of 2-O sulfation is apparently well tolerated in
the presence of high 6-O sulfation [40] (T.H. van Kuppevelt,
unpublished work). In addition, the degree of polymorphism (or
monosaccharide sequence diversity) or density of IdoA2S in a
givenHSoctasaccharidesequence[21]probablyhavedifferential
inhibitoryeffectsonRB4Ea12reactivity.Inlightofthesecaveats,
the HSPGs that are modiﬁed with GlcNS6S-IdoA2S HS chains,
whicharehypothesizedtobeaconservedligandforsporozoitesin
both human and mosquito hosts [15], are likely to be represented
among the well-deﬁned as well as the fainter bands observed in
the immunoblot (Figure 3C, dsGFP control lane). It should be
noted that the proteoglycans themselves remain unaffected by
our RNAi strategy. If these proteoglycans can be cycled to
the salivary gland surface lacking the HSGAG modiﬁcations,
then the polypeptide core itself may contribute unidentiﬁed
binding epitopes for the sporozoite, thus partly explaining our
observations. We are presently pursuing HS epitope analysis for
RB4Ea12aswellasproteomicanalysisoftheA.gambiaesalivary
gland basal lamina to identify the complete repertoire of HS
modiﬁed proteoglycans in this tissue.
It is likely that HSPGs may not be the only molecules that are
important for salivary gland invasion by midgut sporozoites [41].
In a multi-step process, sporozoites invade both the medial lobes
and the distal portion of the lateral lobes of the salivary glands
[42,43]. However, anecdotal evidence from several laboratories
suggeststhat,byandlarge,sporozoitesaremorecommonlyfound
only in the distal lateral lobes. Although HSPGs are seemingly
ubiquitous along the basal membrane of salivary glands, several
basalmoleculeshavealsobeenshowntobeinvolvedinsporozoite
invasion. A monoclonal antibody recognizing the 100 kDa A.
gambiae salivary gland protein saglin was capable of effectively
inhibiting (∼70–100%) sporozoite invasion [44–46]. The role of
saglin in salivary gland invasion is further supported by RNAi
e x p e r i m e n t s ,w h i c hr e s u l ti nu pt o9 8 % inhibition of salivary
gland invasion by sporozoites as compared with controls [44].
Saglin does not contain any predictable GAG modiﬁcation sites
and does not appear to be heavily glycosylated with either N- or
O-glycans. Moreover, it has been determined that TRAP is the
cognate receptor on the sporozoite surface that binds to saglin,
since recombinant TRAP protein fragments have been shown to
bind both mosquito salivary glands and recombinant saglin in
vitro [44]. These results suggest that the interaction of TRAP and
saglin signiﬁcantly inﬂuences salivary gland invasion success.
Although we were able to reduce sporozoite infection of the
salivary glands by inhibiting HS biosynthesis, it is likely that
the unaffected presence of saglin (or another protein) on the
dsAgOXT1-treated salivary glands still supported the successful
invasion of a subset of sporozoites. Conversely, it cannot be
ruled out that salivary gland HSPG core proteins, which remain
unaffected in the saglin RNAi experiments, still contribute to the
initial adhesion of the sporozoite to the glands, since it has not
been shown whether sporozoites can still adhere to the glands,
but not necessarily invade them, given the technical hurdles in
performing such an assay.
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The involvement of several molecules in a multi-step process
was described previously for ookinete invasion of the mosquito
midgut apical microvilli [47]. Although our results are consistent
with a multi-factorial model for tissue invasion, the inherent
biological limitations of the study (e.g. the absence of a salivary
gland cell line) necessitate caution to avoid overextending the
interpretation. Since we cannot measure directly any modulation
on invasion kinetics as a result of the loss of HS in our assay, we
cannotdeﬁnitivelyconcludethatHSisnotinvolved,sinceitcould
very well facilitate sporozoite cell invasion efﬁciency. Moreover,
we know that the rate of turnover for each HSPG inﬂuences the
efﬁcacy of RNAi-mediated suppression. Therefore we recognize
that although our 72 h time point suggests that salivary gland
HSPG turnover is amenable to RNAi, the differential rates of
turnover of speciﬁc HSPGs during our assay’s 48–72 h salivary
gland invasion window limit our interpretation of the data. The
hypothesized conservation in the stratagem for cell invasion
by Plasmodium sporozoites is reasonable, especially in light
of the evidence in the literature regarding the role of HSPGs
in sporozoite-homing to the liver [32,34,36] and the presence
of critical trisulfated ‘conserved’ HS disaccharide moieties on
salivary glands [15]. However, if we assume that the loss of
RB4Ea12 reactivity in the absence of HS biosynthesis results
in the loss of GlcNS6S-IdoA2S HS chains as observed in our
present study, then our results suggest indirectly that although
HSGAGs may contribute to sporozoite attachment and invasion
of salivary glands, their contribution to the process appears to be
moderate. We anticipate that the acquisition of the salivary gland
proteome will be critical in providing additional insight into the
interactions of sporozoites with this tissue.
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